Costs are rising for American health insurance companies, and progress on pre-authorization promises has stalled.

A industry survey shows that UnitedHealth Group and its peers Cigna, Humana, CVS Health, and Aetna are facing rising costs, regulatory scrutiny, and investor concerns. At the same time, groups of healthcare providers say promised pre-authorization reforms have not been realized.